Our Gynecologic Cancer Program specializes in the treatment of cervical, endometrial, ovarian, vaginal and vulvar cancers. We also see women with rare, pregnancy-related cancers, including gestational trophoblastic disease.
The cervix is the portion of the uterus that joins to the vagina. During pregnancy, the cervix remains tightly shut; during labor, the cervix dilates to accommodate the birth of a baby.
Almost all cases of cervical cancer are caused by the human papillomavirus (HPV). However, HPV, doesn’t always cause cervical… Read More ›
Gestational trophoblastic disease (GTD) is a rare group of tumors that involves abnormal cell growth in a woman’s uterus. Unlike other reproductive cancers, the abnormal cells do not develop in a reproductive organ; instead, the tumors develop from cells that would normally grow into the placenta during a pregnancy. GTD… Read More ›
Ovarian cancer (which includes fallopian tube and primary peritoneal cancer) is the most deadly cancer of the female reproductive system. For years, ovarian cancer was known as “the silent killer” because early symptoms are so vague and non-specific that ovarian cancer was usually advanced before it was properly diagnosed. But… Read More ›
The uterus, a pear-shaped organ located in a woman’s pelvis, is composed of three layers. The endometrium, or inner layer, is the tissue that thickens every month in preparation for a potential pregnancy. The myometrium is the middle layer of the uterus and the serosa, or outer layer, covers only… Read More ›
Vaginal and vulvar cancers are extremely rare. Together, they account for less then 5 percent of all female reproductive cancers. Vulvar cancer may be associated with human papillomavirus (HPV) infection, although half of all cases of vulvar cancer occur in women with no history of HPV infection.
Symptoms and Diagnosis
Symptoms of… Read More ›
Learn more about the Gynecologic Cancer Program on the Froedtert & the Medical College of Wisconsin website.